
Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease
Author(s) -
Nileshkumar Patel,
Aashay Patel,
Kanishk Agnihotri,
Dhaval Pau,
Samir Patel,
Badal Thakkar,
Nikhil Nalluri,
Deepak Asti,
Ritesh Kanotra,
Sabeeda Kadavath,
Shilpkumar Arora,
Nilay Patel,
Achint Patel,
Azfar Bilal Sheikh,
Neil Patel,
Apurva Badheka,
Abhishek Deshmukh,
Hakan Paydak,
Juan F. Viles-González
Publication year - 2015
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v7.i7.397
Subject(s) - medicine , atrial fibrillation , heart failure , kidney disease , comorbidity , cardiology , intensive care medicine , disease , population , environmental health
Atrial fibrillation (AF) is the most common type of sustained arrhythmia, which is now on course to reach epidemic proportions in the elderly population. AF is a commonly encountered comorbidity in patients with cardiac and major non-cardiac diseases. Morbidity and mortality associated with AF makes it a major healthcare burden. The objective of our article is to determine the prognostic impact of AF on acute coronary syndromes, heart failure and chronic kidney disease. Multiple studies have been conducted to determine if AF has an independent role in the overall mortality of such patients. Our review suggests that AF has an independent adverse prognostic impact on the clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.